SynthesisJournal of gastrointestinal cancer2026
Effect of Tumor-Associated Sarcopenia on Swallowing Function in Patients with Cancer: a Systematic Review and Meta-Analysis.
Synthesis in Journal of gastrointestinal cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo explore whether the association between tumor-associated sarcopenia and dysphagia generalizes across tumor types and differs between head and neck cancer (HNC) and other cancers.
methodsEligible studies published before December 31, 2024 were retrieved from PubMed, EMBASE, Web of Science, Cochrane Library, CNKI and Wanfang Data. Heterogeneity was evaluated by the I
resultsTwelve studies (n = 2,889) were included. Sarcopenia was significantly associated with dysphagia (OR = 2.82, 95% CI 1.94 to 4.29, P < 0.001) with moderate heterogeneity (I
conclusionsSarcopenia is a universal independent associated factor for dysphagia across cancers, with no difference between HNC and other cancers. Routine screening and targeted interventions may reduce dysphagia risk and improve patient quality of life.
Indexed as
Identifiers
42603192What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.